NASDAQ
OLK

Olink Holding AB ADR

Diagnostics & Research
Healthcare

Prices are adjusted according to historical splits.

Olink Holding AB  ADR Stock Price

Vitals

Today's Low:
$15.515
Today's High:
$16.2699
Open Price:
$15.65
52W Low:
$12.05
52W High:
$26.47
Prev. Close:
$15.65
Volume:
75735

Company Statistics

Market Cap.:
$2.04 billion
Book Value:
3.784
Revenue TTM:
$146.55 million
Operating Margin TTM:
-24.63%
Gross Profit TTM:
$94.50 million
Profit Margin:
-12.34%
Return on Assets TTM:
-4.49%
Return on Equity TTM:
-4.11%

Company Profile

Olink Holding AB ADR had its IPO on 2021-03-25 under the ticker symbol OLK.

The company operates in the Healthcare sector and Diagnostics & Research industry. Olink Holding AB ADR has a staff strength of 667 employees.

Stock update

Shares of Olink Holding AB ADR opened at $15.65 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $15.52 - $16.27, and closed at $16.1.

This is a +2.88% increase from the previous day's closing price.

A total volume of 75,735 shares were traded at the close of the day’s session.

In the last one week, shares of Olink Holding AB ADR have slipped by -1.71%.

Olink Holding AB ADR's Key Ratios

Olink Holding AB ADR has a market cap of $2.04 billion, indicating a price to book ratio of 6.9089 and a price to sales ratio of 21.7066.

In the last 12-months Olink Holding AB ADR’s revenue was $146.55 million with a gross profit of $94.50 million and an EBITDA of $-23840000. The EBITDA ratio measures Olink Holding AB ADR's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Olink Holding AB ADR’s operating margin was -24.63% while its return on assets stood at -4.49% with a return of equity of -4.11%.

In Q2, Olink Holding AB ADR’s quarterly earnings growth was a positive 0% while revenue growth was a positive 7%.

Olink Holding AB ADR’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG

Its diluted EPS in the last 12-months stands at $-0.15 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Olink Holding AB ADR’s profitability.

Olink Holding AB ADR stock is trading at a EV to sales ratio of 20.2933 and a EV to EBITDA ratio of -88.9755. Its price to sales ratio in the trailing 12-months stood at 21.7066.

Olink Holding AB ADR stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$530.50 million
Total Liabilities
$32.85 million
Operating Cash Flow
$0
Capital Expenditure
$3.96 million
Dividend Payout Ratio
0%

Olink Holding AB ADR ended 2024 with $530.50 million in total assets and $0 in total liabilities. Its intangible assets were valued at $530.50 million while shareholder equity stood at $470.50 million.

Olink Holding AB ADR ended 2024 with $0 in deferred long-term liabilities, $32.85 million in other current liabilities, 32221000.00 in common stock, $-98079000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $151.22 million and cash and short-term investments were $151.22 million. The company’s total short-term debt was $1,511,000 while long-term debt stood at $6.72 million.

Olink Holding AB ADR’s total current assets stands at $243.54 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $40.74 million compared to accounts payable of $7.43 million and inventory worth $51.58 million.

In 2024, Olink Holding AB ADR's operating cash flow was $0 while its capital expenditure stood at $3.96 million.

Comparatively, Olink Holding AB ADR paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$16.1
52-Week High
$26.47
52-Week Low
$12.05
Analyst Target Price
$38.25

Olink Holding AB ADR stock is currently trading at $16.1 per share. It touched a 52-week high of $26.47 and a 52-week low of $26.47. Analysts tracking the stock have a 12-month average target price of $38.25.

Its 50-day moving average was $17.22 and 200-day moving average was $20.51 The short ratio stood at 16.18 indicating a short percent outstanding of 0%.

Around 6816.5% of the company’s stock are held by insiders while 3635.1% are held by institutions.

Frequently Asked Questions About Olink Holding AB ADR

The stock symbol (also called stock or share ticker) of Olink Holding AB ADR is OLK

The IPO of Olink Holding AB ADR took place on 2021-03-25

Similar Industry Stocks (Diagnostics & Research)

Last Price
Chg
Chg%
$201.25
1.31
+0.66%
$747.2
-31.85
-4.09%
$20.38
0.38
+1.9%
$7.85
-0.29
-3.56%
$36.08
-1.44
-3.84%
Ipsidy Inc (AUID)
$8.58
-0.76
-8.14%
Bilcare Limited (526853)
$73.83
-1.5
-1.99%
$6.27
-0.33
-5%
$1750.45
-102.55
-5.53%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, service provider, and other institutions that focuses on life science research. The company’s products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; Olink Flex, a low-plex applications and use-cases; and Olink Focus product line that consists of custom developed solutions for customers that has identified various proteins of interest or a protein signature to focus on. Its products also comprise Olink Signature Q100, a qPCR readout platform; Olink Analysis services comprising study design and consultation, sample preparation and assay execution, and data processing and QC; and bioinformatics services. In addition, the company provides Olink normalized protein expression (NPX) Manager, a purpose-built software that enable users to import data, perform data analysis including visualizations, and statistical modelling; and Olink Insight, a cloud platform for Olink community to accelerate proteomics. It sells its products and services through its own direct sales force in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Knilo HoldCo AB and changed its name to Olink Holding AB (publ) in January 2021. The company was founded in 2004 and is headquartered in Uppsala, Sweden. Olink Holding AB (publ) is a subsidiary of Summa Equity Holding AB.

Address

Uppsala Science Park, Uppsala, Sweden, 751 83